Europe's demographic shift and antimicrobial resistance exacerbate sepsis treatment challenges
Original framing: “Why sepsis is becoming harder to treat in Europe” — The Conversation - Global
The original framing omits the historical context of antimicrobial resistance, which has been a growing concern since the 1940s. Indigenous knowledge on traditional medicine and natural remedies for sepsis treatment is also overlooked. Furthermore, the narrative neglects the economic and social determinants of health, such as poverty and access to healthcare, which contribute to the rising sepsis cases.
Medium structural omission detected in mainstream coverage.
This narrative is produced by The Conversation, a global academic publication, for a general audience. The framing serves to highlight the medical challenges of sepsis treatment, while obscuring the underlying structural causes, such as demographic change and antimicrobial resistance. By focusing on the medical response, the narrative reinforces the dominant Western biomedical paradigm.
The history of antimicrobial resistance dates back to the 1940s, when the overuse of antibiotics led to the emergence of resistant bacteria. Since then, the problem has grown exponentially, with the World Health Organization warning of a 'post-antibiotic era' by 2050. Understanding the historical context of antimicrobial resistance is crucial to developing effective strategies to combat it.
The rising sepsis cases in Europe are a symptom of broader societal and economic changes, including demographic shifts and antimicrobial resistance.